Brief: Oryzon Announces Appointment Of Rolando Gutierrez-Esteinou, M.D., As Chief Medical Officer For Cns
Feb 12 (Reuters) - Oryzon Genomics SA ORY.MC: ORYZON ANNOUNCES APPOINTMENT OF ROLANDO GUTIERREZ-ESTEINOU, M.D., AS CHIEF MEDICAL OFFICER FOR CNS Source text: ID:nGNX7h63VX Further company coverage: ORY.MC ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28